Drug Trials Snapshots: FILSPARI
Summary
FILSPARI is an endothelin type A receptor and angiotensin II type 1 receptor antagonist that is indicated to reduce proteinuria in adults with primary immunoglo...
Description
FILSPARI is an endothelin type A receptor and angiotensin II type 1 receptor antagonist that is indicated to reduce proteinuria in adults with primary immunoglo...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source